RIT1 Gene - RIT1, Member of the RAS Oncogene Family

Comprehensive biomedical resource for RIT1: function, mutations, expression, and associated diseases.

Gene Information Card

Symbol RIT1
Full Name Ras-like without CAAX 1
Gene Type protein-coding
Chromosomal Location 1q22
NCBI Gene ID 6016 ncbi.nlm.nih.gov/gene/6016
Ensembl ID ENSG00000143614
UniProt ID Q92963
OMIM ID 609591
HGNC ID 10023
Aliases RIT, RIBB, NS8

Description

RIT1 (Ras-like without CAAX 1) is a member of the RAS subfamily of small GTPases. Unlike classical RAS proteins, RIT1 lacks the C-terminal CAAX motif required for membrane localization and is predominantly cytosolic. It functions as a molecular switch in signal transduction pathways, regulating cell proliferation, differentiation, and survival. Gain-of-function mutations in RIT1 are associated with Noonan syndrome and various cancers, particularly lung adenocarcinoma.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Noonan syndrome Gain-of-function mutations (e.g., p.A57G, p.F82L) enhance GTP binding and downstream MAPK signaling, leading to developmental abnormalities. ClinVar, OMIM
Lung adenocarcinoma Recurrent activating mutations (e.g., p.M90I, p.G95A) promote oncogenic transformation via sustained ERK activation. COSMIC, NCBI
Juvenile myelomonocytic leukemia RIT1 mutations (e.g., p.T83I) identified in JMML patients, contributing to RAS pathway hyperactivation. ClinVar, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.5 Medium
Brain 8.3 Medium
Heart 6.1 Low
Liver 4.2 Low
Kidney 7.9 Medium
Cell Line Expression
Cell Line nTPM Notes
A549 (lung carcinoma) 15.2 High expression; relevant for lung cancer studies
HEK293 (embryonic kidney) 9.8 Moderate expression; used in functional assays
K562 (leukemia) 6.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.A57G Missense <1% Gain-of-function; Noonan syndrome
p.F82L Missense <1% Gain-of-function; Noonan syndrome
p.M90I Missense ~2% in lung adenocarcinoma Gain-of-function; oncogenic
p.G95A Missense <1% Gain-of-function; oncogenic
p.T83I Missense <1% Gain-of-function; JMML
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported; RIT1 is primarily associated with gain-of-function alterations.

Gain of Function (GOF)

Activating missense mutations (e.g., p.A57G, p.F82L, p.M90I) enhance GTP binding and/or reduce GTPase activity, leading to sustained MAPK/ERK signaling.

Dominant Negative (DN)

No dominant-negative mutations described for RIT1.

Pathways

• MAPK signaling pathway (KEGG: hsa04010)
• RAS signaling pathway (KEGG: hsa04014)
• Signaling by RAS mutants (Reactome: R-HSA-9649948)

Protein Summary

RIT1 is a 219-amino-acid small GTPase belonging to the RAS superfamily. It shares structural homology with classical RAS proteins but lacks a CAAX motif, resulting in cytosolic localization. RIT1 cycles between an active GTP-bound state and an inactive GDP-bound state, regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Active RIT1 engages downstream effectors such as RAF kinases, leading to MAPK pathway activation. Mutations that impair GTP hydrolysis or enhance nucleotide exchange cause constitutive signaling, underlying Noonan syndrome and oncogenesis.

Related Products

Product name Cat.No. Species Gene ID
RIT1 Knockout HEK293 Cell Line EDJ-KQ2646 Human 6016 Details Get a Quote
RIT1 Knockout HeLa Cell Line EDJ-KQ22042 Human 6016 Details Get a Quote
RIT1 Knockout A-549 Cell Line EDJ-KQ23409 Human 6016 Details Get a Quote
RIT1 Knockout HCT 116 Cell Line EDJ-KQ23410 Human 6016 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: